JP2023534916A5 - - Google Patents
Info
- Publication number
- JP2023534916A5 JP2023534916A5 JP2022581408A JP2022581408A JP2023534916A5 JP 2023534916 A5 JP2023534916 A5 JP 2023534916A5 JP 2022581408 A JP2022581408 A JP 2022581408A JP 2022581408 A JP2022581408 A JP 2022581408A JP 2023534916 A5 JP2023534916 A5 JP 2023534916A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046133P | 2020-06-30 | 2020-06-30 | |
| US63/046,133 | 2020-06-30 | ||
| US202063052093P | 2020-07-15 | 2020-07-15 | |
| US63/052,093 | 2020-07-15 | ||
| US202063071092P | 2020-08-27 | 2020-08-27 | |
| US63/071,092 | 2020-08-27 | ||
| PCT/US2021/039911 WO2022006283A2 (en) | 2020-06-30 | 2021-06-30 | Methods of treating neuromyelitis optica spectrum disorder |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023534916A JP2023534916A (ja) | 2023-08-15 |
| JP2023534916A5 true JP2023534916A5 (https=) | 2024-07-09 |
| JPWO2022006283A5 JPWO2022006283A5 (https=) | 2024-07-09 |
Family
ID=79321915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581408A Pending JP2023534916A (ja) | 2020-06-30 | 2021-06-30 | 視神経脊髄炎スペクトラム障害を治療する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230406928A1 (https=) |
| EP (1) | EP4172211A4 (https=) |
| JP (1) | JP2023534916A (https=) |
| KR (1) | KR20230030642A (https=) |
| CN (1) | CN116234571A (https=) |
| AU (1) | AU2021299307A1 (https=) |
| BR (1) | BR112022026747A2 (https=) |
| CA (1) | CA3178954A1 (https=) |
| IL (1) | IL299381A (https=) |
| MX (1) | MX2022016236A (https=) |
| WO (1) | WO2022006283A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023549075A (ja) * | 2020-10-29 | 2023-11-22 | ビエラ バイオ インコーポレイテッド | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
| CN117797245A (zh) * | 2023-12-29 | 2024-04-02 | 广州赛莱拉干细胞科技股份有限公司 | 人乳脂球表皮生长因子8用于制备治疗视神经脊髓炎谱系疾病药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021012870A (es) * | 2019-04-24 | 2022-01-18 | Viela Bio Inc | Uso de un anticuerpo anti cúmulo de diferenciación 19 (cd19) para tratar enfermedades autoinmunitarias. |
| JP2023549075A (ja) * | 2020-10-29 | 2023-11-22 | ビエラ バイオ インコーポレイテッド | 自己免疫疾患を治療するための抗ｃｄ１９抗体の使用 |
-
2021
- 2021-06-30 JP JP2022581408A patent/JP2023534916A/ja active Pending
- 2021-06-30 CN CN202180046409.5A patent/CN116234571A/zh active Pending
- 2021-06-30 MX MX2022016236A patent/MX2022016236A/es unknown
- 2021-06-30 AU AU2021299307A patent/AU2021299307A1/en active Pending
- 2021-06-30 BR BR112022026747A patent/BR112022026747A2/pt unknown
- 2021-06-30 IL IL299381A patent/IL299381A/en unknown
- 2021-06-30 WO PCT/US2021/039911 patent/WO2022006283A2/en not_active Ceased
- 2021-06-30 KR KR1020237002980A patent/KR20230030642A/ko active Pending
- 2021-06-30 EP EP21834411.7A patent/EP4172211A4/en active Pending
- 2021-06-30 CA CA3178954A patent/CA3178954A1/en active Pending
-
2022
- 2022-12-28 US US18/147,287 patent/US20230406928A1/en active Pending